HSBC Holdings
SRRA

HSBC Holdings’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

HSBC Holdings’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-58,631
Closed -$3.22M – 3432
2022
Q2 		$3.22M Buy
+58,631
New +$3.08M ﹤0.01% 1368

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

HSBC Holdings's SRRA Position: Q3 2022 in Review

HSBC Holdings sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 58,631 shares — an estimated $3.22M sold.

HSBC Holdings first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $3.22M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • HSBC Holdings reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • HSBC Holdings sold 58,631 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $3.22M.
  • HSBC Holdings first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • HSBC Holdings's Sierra Oncology, Inc. Common Stock position peaked at $3.22M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on HSBC Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.